Resuscitation Devices Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,850	100 Pages	Fortune Business Insights Pvt. Ltd.	September, 2024	FOB19185745

Best Price Guarantee
Price	from $4,850
Length	100 Pages
Publisher	Fortune Business Insights Pvt. Ltd.
Published Date	September, 2024
SKU	FOB19185745

Resuscitation Devices Market

Growth Factors of Resuscitation Devices Market

The resuscitation devices market size was valued at USD 4.78 billion in 2023, and the market is now projected to grow from USD 5.06 billion in 2024 to USD 9.00 billion by 2032, exhibiting a CAGR of 7.5% during the forecast period of 2024-2032.

During the pandemic in 2020, the global market for resuscitation system declined due to fewer accidents, emergency times, and health centre admissions. The market grew notably in 2021 and 2022, pushed through boom in clinic visits.

The global occurrence of cardiovascular illnesses, persistent obstructive pulmonary disease (COPD), and cardiac arrest is growing. COPD prevalence is also growing internationally, with 8.9% in Latin America and the Caribbean and 13.7% amongst person adult males. This has raised the demand for emergency treatment and sanatorium admissions. Because of the growing variety of preterm infants, the demand for resuscitation tool and vital care in ambulances has grown as well.

The incidence of cardiovascular and pulmonary troubles has dramatically expanded. Globally, neonatal respiration illnesses and emergency clinical conditions desiring resuscitation tool are on the rise. The developing incidence of cardiac arrest and respiratory issues has delivered approximately expanded name for the ones gadgets the world over. To meet developing demand, company people prioritize new product introductions.

Comprehensive Analysis of Resuscitation Devices Market

The market for airway control devices, emergency care ventilators, and defibrillators is segmented based on product type, with the ventilators phase dominating because of the rising prevalence of COPD and demand. The ventilators phase is predicted to grow at a sizable CAGR due to elevated emergency care visits and new product launches. The end-person phase is split into hospitals and ASCs, homecare, and others, with hospitals and ASCs dominating due to increased emergency branch visits and homecare growing because of surprising cardiac arrest cases, geriatric population, and attention of emergency resuscitation gadgets.

The North America region lead the resuscitation devices market share by benefitting a market size of USD 2.44 billion in 2023 due to the rising incidence of sudden cardiac arrests within the US has raised recognition approximately the significance of using these devices because the first line of emergency therapy. This factor has been driving resuscitation devices market growth inside the vicinity.

In 2023, Getinge AB, Ambu A/S, and Teleflex Incorporated dominated the worldwide resuscitation gadgets marketplace, commonly due to their focus on technologically superior devices. Other key players, like Koninklijke Philips N.V., Hamilton Medical, and Getinge AB, expanded manufacturing ability to boost revenue. Collaborations with the U.S. Government in 2020 helped fight COVID-19.

In July 2023, Ambu A/S introduced that its lung air flow system, VivaSigh 2 SLT, is prepared for European commercialization.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 7.5% from 2024-2032

Unit Value (USD billion)

Segmentation By Product

- Airway Management Devices

Infraglottic Devices
Supraglottic Devices
Laryngoscopes
Others

- Emergency Care Ventilators

- Defibrillators

By End-user

- Hospitals and ASCs

- Homecare

- Others

By Region

- North America (by Product, by End-user, and by Country)

U.S.
Canada

- Europe (by Product, by End-user, and by Country/Sub-region)

U.K.
Germany
France
Spain
Italy
Scandinavia
Rest of Europe

- Asia Pacific (by Product, by End-user, and by Country/Sub-region)

Japan
China
Australia
India
Southeast Asia
Rest of Asia Pacific

- Latin America (by Product, by End-user, and by Country/Sub-region)

Brazil
Mexico
Rest of Latin America

- Middle East and Africa (by Product, by End-user, and by Country/Sub-region)

South Africa
GCC
Rest of Middle East and Africa

Please Note:

1. Introduction: 1.1. Research Scope; 1.2. Market Segmentation; 1.3. Research Methodology; 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics: 3.1. Market Drivers; 3.2. Market Restraints; 3.3. Market Opportunities; 3.4. Market Trends
4. Key Insights: 4.1. Prevalence of Chronic Obstructive Pulmonary Disease – by Key Countries/Sub-region, 2022/2023; 4.2. Prevalence of Asthama – by Key Countries/Sub-region, 2022/2023; 4.3. New Product Launches; 4.4. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.); 4.5. Impact of COVID-19 on the Market
5. Global Resuscitation Devices Market Analysis, Insights and Forecast, 2019-2032: 5.1. Market Analysis, Insights and Forecast – By Product; 5.1.1. Airway Management Devices; 5.1.1.1. Infraglottic Devices; 5.1.1.2. Supraglottic Devices; 5.1.1.3. Laryngoscopes; 5.1.1.4. Others; 5.1.2. Emergency Care Ventilators; 5.1.3. Defibrillator; 5.2. Market Analysis, Insights and Forecast – By End-user; 5.2.1. Hospitals & ASCs; 5.2.2. Homecare; 5.2.3. Others; 5.3. Market Analysis, Insights and Forecast – By Region; 5.3.1. North America; 5.3.2. Europe; 5.3.3. Asia Pacific; 5.3.4. Latin America; 5.3.5. Middle East & Africa
6. North America Resuscitation Devices Market Analysis, Insights and Forecast, 2019-2032: 6.1. Market Analysis, Insights and Forecast – By Product; 6.1.1. Airway Management Devices; 6.1.1.1. Infraglottic Devices; 6.1.1.2. Supraglottic Devices; 6.1.1.3. Laryngoscopes; 6.1.1.4. Others; 6.1.2. Emergency Care Ventilators; 6.1.3. Defibrillator; 6.2. Market Analysis, Insights and Forecast – By End-user; 6.2.1. Hospitals & ASCs; 6.2.2. Homecare; 6.2.3. Others; 6.3. Market Analysis, Insights and Forecast – By Country; 6.3.1. U.S.; 6.3.2. Canada
7. Europe Resuscitation Devices Market Analysis, Insights and Forecast, 2019-2032: 7.1. Market Analysis, Insights and Forecast – By Product; 7.1.1. Airway Management Devices; 7.1.1.1. Infraglottic Devices; 7.1.1.2. Supraglottic Devices; 7.1.1.3. Laryngoscopes; 7.1.1.4. Others; 7.1.2. Emergency Care Ventilators; 7.1.3. Defibrillator; 7.2. Market Analysis, Insights and Forecast – By End-user; 7.2.1. Hospitals & ASCs; 7.2.2. Homecare; 7.2.3. Others; 7.3. Market Analysis, Insights and Forecast – By Country/Sub-Region; 7.3.1. Germany; 7.3.2. U.K.; 7.3.3. France; 7.3.4. Italy; 7.3.5. Spain; 7.3.6. Rest of Europe
8. Asia Pacific Resuscitation Devices Market Analysis, Insights and Forecast, 2019-2032: 8.1. Market Analysis, Insights and Forecast – By Product; 8.1.1. Airway Management Devices; 8.1.1.1. Infraglottic Devices; 8.1.1.2. Supraglottic Devices; 8.1.1.3. Laryngoscopes; 8.1.1.4. Others; 8.1.2. Emergency Care Ventilators; 8.1.3. Defibrillator; 8.2. Market Analysis, Insights and Forecast – By End-user; 8.2.1. Hospitals & ASCs; 8.2.2. Homecare; 8.2.3. Others; 8.3. Market Analysis, Insights and Forecast – By Country/Sub-Region; 8.3.1. China; 8.3.2. Japan; 8.3.3. India; 8.3.4. Australia; 8.3.5. Southeast Asia; 8.3.6. Rest of Asia Pacific
9. Latin America Resuscitation Devices Market Analysis, Insights and Forecast, 2019-2032: 9.1. Market Analysis, Insights and Forecast – By Product; 9.1.1. Airway Management Devices; 9.1.1.1. Infraglottic Devices; 9.1.1.2. Supraglottic Devices; 9.1.1.3. Laryngoscopes; 9.1.1.4. Others; 9.1.2. Emergency Care Ventilators; 9.1.3. Defibrillator; 9.2. Market Analysis, Insights and Forecast – By End-user; 9.2.1. Hospitals & ASCs; 9.2.2. Homecare; 9.2.3. Others; 9.3. Market Analysis, Insights and Forecast – By Country/Sub-Region; 9.3.1. Brazil; 9.3.2. Mexico; 9.3.3. Rest of Latin America
10. Latin America Resuscitation Devices Market Analysis, Insights and Forecast, 2019-2032: 10.1. Market Analysis, Insights and Forecast – By Product; 10.1.1. Airway Management Devices; 10.1.1.1. Infraglottic Devices; 10.1.1.2. Supraglottic Devices; 10.1.1.3. Laryngoscopes; 10.1.1.4. Others; 10.1.2. Emergency Care Ventilators; 10.1.3. Defibrillator; 10.2. Market Analysis, Insights and Forecast – By End-user; 10.2.1. Hospitals & ASCs; 10.2.2. Homecare; 10.2.3. Others; 10.3. Market Analysis, Insights and Forecast – By Country/Sub-Region; 10.3.1. South Africa; 10.3.2. GCC; 10.3.3. Rest of Middle East & Africa
11. Competitive Analysis: 11.1. Global Market Share Analysis (2023); 11.2. Company Profiles; 11.2.1. Koninklijke Philips N.V.; 11.2.1.1. Overview; 11.2.1.2. Products & Services; 11.2.1.3. SWOT Analysis; 11.2.1.4. Recent Developments; 11.2.1.5. Strategies; 11.2.1.6. Financials (Based on Availability); 11.2.2. Hamilton Medical; 11.2.2.1. Overview; 11.2.2.2. Products & Services; 11.2.2.3. SWOT Analysis; 11.2.2.4. Recent Developments; 11.2.2.5. Strategies; 11.2.2.6. Financials (Based on Availability); 11.2.3. Getinge AB; 11.2.3.1. Overview; 11.2.3.2. Products & Services; 11.2.3.3. SWOT Analysis; 11.2.3.4. Recent Developments; 11.2.3.5. Strategies; 11.2.3.6. Financials (Based on Availability); 11.2.4. Medtronic; 11.2.4.1. Overview; 11.2.4.2. Products & Services; 11.2.4.3. SWOT Analysis; 11.2.4.4. Recent Developments; 11.2.4.5. Strategies; 11.2.4.6. Financials (Based on Availability); 11.2.5. Teleflex Incorporated; 11.2.5.1. Overview; 11.2.5.2. Products & Services; 11.2.5.3. SWOT Analysis; 11.2.5.4. Recent Developments; 11.2.5.5. Strategies; 11.2.5.6. Financials (Based on Availability); 11.2.6. Convatec Group PLC; 11.2.6.1. Overview; 11.2.6.2. Products & Services; 11.2.6.3. SWOT Analysis; 11.2.6.4. Recent Developments; 11.2.6.5. Strategies; 11.2.6.6. Financials (Based on Availability); 11.2.7. Ambu A/S; 11.2.7.1. Overview; 11.2.7.2. Products & Services; 11.2.7.3. SWOT Analysis; 11.2.7.4. Recent Developments; 11.2.7.5. Strategies; 11.2.7.6. Financials (Based on Availability); 11.2.8. Flexicare Medical Limited; 11.2.8.1. Overview; 11.2.8.2. Products & Services; 11.2.8.3. SWOT Analysis; 11.2.8.4. Recent Developments; 11.2.8.5. Strategies; 11.2.8.6. Financials (Based on Availability); 11.2.9. ICU Medical; 11.2.9.1. Overview; 11.2.9.2. Products & Services; 11.2.9.3. SWOT Analysis; 11.2.9.4. Recent Developments; 11.2.9.5. Strategies; 11.2.9.6. Financials (Based on Availability); 11.2.10. ZOLL Medical Corporation (Asahi Kasei); 11.2.10.1. Overview; 11.2.10.2. Products & Services; 11.2.10.3. SWOT Analysis; 11.2.10.4. Recent Developments; 11.2.10.5. Strategies; 11.2.10.6. Financials (Based on Availability); 11.2.11. Stryker; 11.2.11.1. Overview; 11.2.11.2. Products & Services; 11.2.11.3. SWOT Analysis; 11.2.11.4. Recent Developments; 11.2.11.5. Strategies; 11.2.11.6. Financials (Based on Availability)